Randomized Controlled Trial
Copyright ©The Author(s) 2016.
World J Gastroenterol. Aug 28, 2016; 22(32): 7373-7382
Published online Aug 28, 2016. doi: 10.3748/wjg.v22.i32.7373
Table 1 Patient characteristics
CO2 groupAir groupP value
Total No. of patients2422
Sex, M/F21/319/30.7460
Age (yr, mean ± SD)67.5 ± 5.872.0 ± 7.20.7718
Location1
Cervical esophagus (Ce)000.6015
Upper thoracic esophagus (Ut)24
Middle thoracic esophagus (Mt)1711
Lower thoracic esophagus (Lt)44
Abdominal esophagus (Ae)13
Histology1
Squamous cell carcinoma23190.3364
Barrett’s adenocarcinoma13
Histological depth1
EP560.1734
LPM119
MM46
SM101
SM240
Tumor size (mm, mean ± SD)26.6 ± 14.427.4 ± 22.90.8955
Resection size (mm, mean ± SD)40.0 ± 14.142.3 ± 21.20.6620
En-bloc resection2422-
R0 resection22200.9378
HM+110.5087
VM+100.9649
Ly+00-
V+130.3364
Procedure time (min, mean ± SD)69.2 ± 28.165.0 ± 39.20.6847
Table 2 Effect of CO2 insufflation vs air insufflation (mean ± SD)
CO2 groupAir groupP value
Gas volume in the GI tract
Immediately after ESD (mL)803 ± 3711173 ± 5800.0128
Next day (mL)300 ± 136304 ± 2150.9449
End-tidal carbon dioxide partial pressure (EtCO2) measurements
Baseline EtCO2 level (mmHg)38.2 ± 3.638.1 ± 4.10.7543
Maximum EtCO2 level (mmHg)45.9 ± 4.144.3 ± 6.70.8562
Oxygen saturation (SpO2) measurements
Baseline SpO2 level (%)98.9 ± 1.398.4 ± 1.00.2762
Minimum SpO2 level (%)93.7 ± 3.493.9 ± 2.30.8198
Sedative drugs
Propofol dose (mg)537 ± 258610 ± 5330.5655
Pentazocine hydrochloride dose (mg)27.2 ± 4.527.1 ± 5.80.9658
Droperidol used, No. of patients520.4859
Droperidol dose (mg)3.0 ± 1.12.5 ± 0.00.5761
Table 3 Clinical course
CO2 groupAir groupP value
Fever ≥ 38 °C8.3%9.1%0.6652
Duration of fever ≥ 38 °C (d)1.5 ± 0.72.0 ± 1.40.6984
Duration of fasting, d2.4 ± 0.82.1 ± 0.20.1639
Complications
Perforation0%0%-
Post-procedure hemorrhage0%0%-
Esophageal stricture with dysphagia8.3%9.1%0.6652
Pneumonia0%0%-
Death0%0%-